hVIVO (LON:HVO) Shares Break Below Fifty Day Moving Average – Here’s What Happened

hVIVO plc (LON:HVO) crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of GBX 6.58 and traded as low as GBX 5.60. hVIVO shares last traded at GBX 5.75, with a volume of 2,097,509 shares trading hands.

hVIVO Stock Performance

The stock has a 50-day simple moving average of GBX 6.56 and a 200-day simple moving average of GBX 7.18. The company has a debt-to-equity ratio of 43.38, a current ratio of 1.21 and a quick ratio of 1.16. The stock has a market cap of £42.34 million, a PE ratio of -3.46 and a beta of 1.69.

hVIVO (LON:HVO) last announced its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.82) earnings per share for the quarter. hVIVO had a negative net margin of 31.76% and a negative return on equity of 35.13%. Equities analysts predict that hVIVO plc will post 1.5492958 earnings per share for the current fiscal year.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers.